Abstract
Head and neck (HN) cancer is a significant health-care problem worldwide. One of the major prognostic factors for squamous cell carcinomas of the head and neck (HNSCC) is metastasis. Early detection of lymph node metastasis and the identification of key protein targets for the treatment of metastatic HNSCC remain a challenge in current cancer research. Recent developments in molecular analysis technologies, such as DNA microarray and proteomic analyses, have provided powerful tools for the detection of metastatic signatures in primary tumors, opening new avenues toward the molecular diagnosis and prognosis of HN cancers. Evaluation of gene expression profiling identified in metastatic signatures has further facilitated the understanding of HNSCC metastasis at the molecular level. This review will focus on current exploration of metastatic proteins in HNSCC with an emphasis on molecular signatures of metastatic HNSCC in order to understand the functions of metastasis-related proteins involved in adhesion, invasion, dissemination, and survival, and to define appropriate biomarkers and targets for the treatment of this disease.
Keywords: DNA microarray, chemokine receptors, matrix metalloproteinases, tumors, mitogen-activated protein kinase
Current Cancer Drug Targets
Title: Exploration of Metastasis-related Proteins as Biomarkers and Therapeutic Targets in the Treatment of Head and Neck Cancer
Volume: 7 Issue: 7
Author(s): Zhuo (Georgia) Chen
Affiliation:
Keywords: DNA microarray, chemokine receptors, matrix metalloproteinases, tumors, mitogen-activated protein kinase
Abstract: Head and neck (HN) cancer is a significant health-care problem worldwide. One of the major prognostic factors for squamous cell carcinomas of the head and neck (HNSCC) is metastasis. Early detection of lymph node metastasis and the identification of key protein targets for the treatment of metastatic HNSCC remain a challenge in current cancer research. Recent developments in molecular analysis technologies, such as DNA microarray and proteomic analyses, have provided powerful tools for the detection of metastatic signatures in primary tumors, opening new avenues toward the molecular diagnosis and prognosis of HN cancers. Evaluation of gene expression profiling identified in metastatic signatures has further facilitated the understanding of HNSCC metastasis at the molecular level. This review will focus on current exploration of metastatic proteins in HNSCC with an emphasis on molecular signatures of metastatic HNSCC in order to understand the functions of metastasis-related proteins involved in adhesion, invasion, dissemination, and survival, and to define appropriate biomarkers and targets for the treatment of this disease.
Export Options
About this article
Cite this article as:
Chen (Georgia) Zhuo, Exploration of Metastasis-related Proteins as Biomarkers and Therapeutic Targets in the Treatment of Head and Neck Cancer, Current Cancer Drug Targets 2007; 7 (7) . https://dx.doi.org/10.2174/156800907782418301
DOI https://dx.doi.org/10.2174/156800907782418301 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapy Related Markers and Response Prediction Towards Multimodal Treatment of Carcinomas of the Upper Gastrointestinal Tract
Current Pharmacogenomics and Personalized Medicine PET in Anti-Cancer Drug Development and Therapy
Recent Patents on Anti-Cancer Drug Discovery Design, Synthesis, and In Silico Studies of Novel N-(2-Aminophenyl)-2,3- Diphenylquinoxaline-6-Sulfonamide Derivatives Targeting Receptor- Binding Domain (RBD) of SARS-CoV-2 Spike Glycoprotein and their Evaluation as Antimicrobial and Antimalarial Agents
Letters in Drug Design & Discovery Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications
Current Drug Targets New Ways to Improve Breast Cancer Therapy Targeting Specific Molecular Pathways
Current Cancer Therapy Reviews Novel Therapeutic Strategies in Infection and Cancer Management
Current Aging Science Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches
Current Medicinal Chemistry Exploring the Synthesis and Anticancer Potential of L-Tyrosine-Platinum(II) Hybrid Molecules
Medicinal Chemistry Recent Patents Concerning Modulators of Protein Kinase C
Recent Patents on DNA & Gene Sequences Recent Progress in the Identification and Clinical Evaluation of Inhibitors of the Mitotic Kinesin KSP
Current Topics in Medicinal Chemistry Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Imaging of Hypoxia Using PET and MRI
Current Pharmaceutical Biotechnology Phytochemicals as Adjunctive with Conventional Anticancer Therapies
Current Pharmaceutical Design The “Big Five” Phytochemicals Targeting Cancer Stem Cells: Curcumin, EGCG, Sulforaphane, Resveratrol and Genistein
Current Medicinal Chemistry Clinical Significance of Umami Taste and Umami-Related Gene Expression Analysis for the Objective Assessment of Umami Taste Loss
Current Pharmaceutical Design Multimodality Imaging of RNA Interference
Current Medicinal Chemistry Stem Cells Derived from Human Exfoliated Deciduous Teeth (SHED) in Neuronal Disorders: A Review
Current Stem Cell Research & Therapy Signal Transduction Inhibitors as Radiosensitizers
Current Medicinal Chemistry - Anti-Cancer Agents Role of Rap2 and its Downstream Effectors in Tumorigenesis
Anti-Cancer Agents in Medicinal Chemistry Natural Products Targeting EGFR Signaling Pathways as Potential Anticancer Drugs
Current Protein & Peptide Science